Dissertations / Theses on the topic 'Multiprotein complexes'

Aperçu du contrôle de la dégradation des ARNm par les protéines YTHpendant la transition de la méiose à la mitose chez les levures.Le cycle cellulaire est contrôlé par des processus complexes et interconnectés. Un gène est transcrit en ARNm qui est traduit en protéines mais de nombreux processus de régulation travaillent pour contrôler chaque étape de ce processus apparemment simple. Parmi ces points de contrôle, la régulation post-transcriptionnelle est importante, et la formation d'un complexe protéine-ARN peut diriger le destin cellulaire. Parmi ces protéines de liaison à l'ARN, les protéines contenant des domaines YTH n’ont été découvertes qu’à la fin des années 90. Les protéines contenant des domaines YTH sont abondantes chez les eucaryotes et absentes chez les procaryotes. Elles constituent la majorité des protéines « readers » capables de reconnaître spécifiquement la modification m6A. L’Homme possède cinq protéines YTH, YTHDF1-3, YTHDC1,2 (Hazra, D., C. Chapat, et Graille, M. (2019). Destin de l'ARNm de m6A : enchaînés au rythme par les protéines contenant de la YTH. , 10 (1), 49.). Bien qu'il soit évident que ces protéines contrôlent le destin cellulaire, la fonction de chaque protéine et son réseau d’interaction restent à élucider. Chez les levures, une seule protéine YTH est présente: Pho92 chez Saccharomyces cerevisiae et Mmi1 chez Schizosaccharomyces pombe. Hormis le domaine YTH, il n'y a pas d'homologie de séquence entre ces deux protéines mais leur fonction cellulaire est similaire.Il est bien établi que Mmi1 est responsable de la dégradation des transcrits spécifiques de la méiose au cours de la croissance végétative des cellules chez la levure S. pombe. Mmi1 forme un complexe stable avec une petite protéine, Erh1 (complexe Erh1-Mmi1 ou EMC). Le complexe EMC peut physiquement interagir avec la sous-unité Not1 du complexe CCR4-Not et la recruter pour la dégradation des ARNm contenant des motifs DSR (déterminant de l'élimination sélective). L'action de Mmi1 est à son tour régulée par une protéine possédant un domaine RRM, Mei2. Au cours de la méiose, Mei2, avec l’aide d’un lncRNA meiRNA, séquestre Mmi1 dans un point nucléaire, le rendant inactif et assurant la continuité de la méiose. Ces trois protéines, Mmi1-Erh1-Mei2, jouent un rôle clé dans la transition de la mitose vers la méiose.Chez S. cerevisiae, Pho92 est impliquée dans la dégradation des transcrits de PHO4, contribuant à la voie du métabolisme du phosphate, pendant la privation en phosphate et participe également à la dégradation des ARNm contenant les marques épitranscriptomiques de N6-méthyladénosine (m6A). Comme pour S. pombe Mmi1, Pho92 recrute le complexe CCR4-Not via une interaction physique avec Not1.Au cours de ma thèse, j'ai tenté d'élucider le rôle de ces deux protéines du domaine YTH de deux organismes modèles, S. cerevisiae et S. pombe, dans la dégradation de l'ARNm et la régulation du cycle cellulaire par des approches biochimiques et structurales.Pho92 de S. cerevisiae interagit physiquement avec Not1 du complexe CCR4-Not, nous avons pu déterminer les limites des domaines impliqués dans cette interaction. L’interaction entre ces deux protéines a été étudiée par anisotropie de fluorescence. Le complexe protéique a été purifié avec succès et des essais de cristallisation sont en cours.Chez S. pombe, la structure de Mei2-RRM3 a été résolue avec et sans ARN. Les propriétés de liaison à l'ARN de Mei2-RRM3 ont été étudiées par ITC. La structure de Erh1 a également été résolue révélant une organisation en homodimere. Nous avons montré que la formation de cet homodimere est important pour la fonction biologique de Mmi1. Des essais de co-cristallisation ont été réalisés avec de l'ARN et les protéines Mmi1 et Mei2, mais sans succès et nous avons obtenu des cristaux de Mmi1<br>Insights into the control of mRNA decay by YTH proteinsduring the transition from meiosis to mitosis in yeasts.Keywords: Epitranscriptomics, mRNA decay, meiosis, multi-protein complexes, YTH domainCell cycle is controlled by multi-layered processes. A gene is transcribed in mRNA which is translated in proteins but innumerable regulation processes are working to control every step of this apparently simple process. Among these regulatory check points, post-transcriptional regulation is an important one, where formation of a protein-RNA complex may direct the cellular fate. Among these RNA binding proteins, YTH domain proteins are most novel, discovered in late 90s. YTH domain proteins are abundant in eukaryotes and absent in prokaryotes. YTH domain proteins constitute the majority of reader proteins that can specifically identify m6A modification. Human beings have five YTH domain proteins YTHDF1-3, YTHDC1-2 (Hazra, D., Chapat, C., &amp; Graille, M. (2019). m6A mRNA Destiny: Chained to the rhYTHm by the YTH-Containing Proteins. Genes, 10(1), 49.). Although it is evident that these proteins are controlling cellular fate, the function of each protein and their network is yet to be elucidated. In yeast, there is only one YTH domain protein present: Pho92 in Saccharomyces cerevisiae and Mmi1 in Schizosaccharomyces pombe. Apart from the YTH domain there is no sequence homology between these two proteins but their cellular function is similar.It is well established that Mmi1 is responsible for degradation of meiosis specific transcripts during vegetative growth of the cell. Mmi1 forms a tight complex with a small protein, Erh1 (Erh1-Mmi1 complex or EMC). EMC can physically interact with Not1 of CCR4-Not complex and recruit it for degradation of DSR (determinant of selective removal) containing RNAs. The action of Mmi1 is in turn regulated by an RRM domain protein, Mei2. During meiosis, Mei2, along with a lncRNA meiRNA sequesters Mmi1 in a nuclear dot, rendering it inactive and ensuring smooth continuance of meiosis. These three proteins, Mmi1-Erh1-Mei2 play a key role in mitosis to meiosis switch.In S. cerevisiae, Pho92 is involved in the degradation of PHO4 transcripts contributing to phosphate metabolism pathway, during phosphate starvation and also participates in the degradation of mRNAs containing the N6-methyladenosine (m6A) epitranscriptomics marks. Similarly, to S. pombe Mmi1, Pho92 recruits CCR4-Not complex by physical interaction with Not1.During my PhD, I have tried to elucidate the role of these two YTH domain proteins from two model organisms, S. cerevisiae and S. pombe, in mRNA degradation and cell cycle regulation using biochemical and structural approaches.Pho92 of S. cerevisiae physically interacts with Not1 of CCR4-Not complex, we were able to determine the boundaries of this interaction. The interaction between these two proteins was studied by Fluorescence anisotropy. The protein complex was successfully purified and crystallization trials are ongoing.From S. pombe, structure of Mei2-RRM3 was solved with and without an RNA. RNA binding properties of Mei2-RRM3 was studied by ITC. The structure of Erh1 was also solved and we tried to elucidate its importance for biological function of Mmi1. A co-crystallization trial was performed with Mmi1-Mei2-RNA but it was unsuccessful and we ended up with Mmi1 crystals

Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, develops through progression of premalignant pancreatic intraepithelial neoplasias (PanINs). In mouse-models, KRAS-activation in acinar cells induced an acinar-to-ductal metaplasia (ADM), and mutation of the Kras oncogene is believed to initiate PanIN formation. ADM is also promoted by pancreatic injury, which cooperates with activated KRAS to stimulate PanIN and PDAC formation from metaplastic ducts. Our lab, and others, have shown that the downstream PI3K/AKT pathway is important for KRAS-mediated proliferation and survival in vitro and in vivo. Prior studies have demonstrated that full activation of AKT requires both PDK1- mediated phosphorylation of AKTT308 and mTOR complex 2 (mTORC2)-mediated phosphorylation of AKTS473. Given the importance of the PI3K/AKT signaling axis, I hypothesized that mTORC2 is required for KRAS-driven pancreatic tumorigenesis and investigated this relationship in mice by combining pancreasspecific expression of an activated KRASG12D molecule with deletion of the essential mTORC2 subunit RICTOR. In the context of activated KRAS, Rictor-null pancreata developed fewer PanIN lesions; these lesions lacked mTORC2 signaling and their proliferation and progression were impaired. Higher levels of nuclear cyclin dependent kinase inhibitors (CDKIs) were maintained in Rictor-null lesions, and nuclear BMI1, a known regulator of the CDKI Cdkn2a, inversely correlated with their expression.Rictor was not required for KRAS-driven ADM following acute pancreatitis, however the inverse correlation between CDKIs and BMI1 was maintained in this system. Treatment of PDX-Cre;KRASG12D/+;Trp53R172H/+ mice with an mTORC1/2 inhibitor delayed tumor formation, and prolonged the survival of mice with late stage PDAC. Knockdown of Rictor in established PDAC cell lines impaired proliferation and anchorage independent growth supporting a role for mTORC2 in fully transformed cells. These data suggest that mTORC2 cooperates with activated KRAS in the initiation and progression of PanIN lesions and is required for the transformation and maintenance of PDAC. My work illustrates phenotypic differences between pancreatic loss of Rictor and PDK1 in the context of KRAS, broadens our understanding of this signaling node and suggests that mTORC2 may potentially be a viable target for PDAC therapies.

Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, develops through progression of premalignant pancreatic intraepithelial neoplasias (PanINs). In mouse-models, KRAS-activation in acinar cells induced an acinar-to-ductal metaplasia (ADM), and mutation of the Kras oncogene is believed to initiate PanIN formation. ADM is also promoted by pancreatic injury, which cooperates with activated KRAS to stimulate PanIN and PDAC formation from metaplastic ducts. Our lab, and others, have shown that the downstream PI3K/AKT pathway is important for KRAS-mediated proliferation and survival in vitro and in vivo. Prior studies have demonstrated that full activation of AKT requires both PDK1- mediated phosphorylation of AKTT308 and mTOR complex 2 (mTORC2)-mediated phosphorylation of AKTS473. Given the importance of the PI3K/AKT signaling axis, I hypothesized that mTORC2 is required for KRAS-driven pancreatic tumorigenesis and investigated this relationship in mice by combining pancreasspecific expression of an activated KRASG12D molecule with deletion of the essential mTORC2 subunit RICTOR. In the context of activated KRAS, Rictor-null pancreata developed fewer PanIN lesions; these lesions lacked mTORC2 signaling and their proliferation and progression were impaired. Higher levels of nuclear cyclin dependent kinase inhibitors (CDKIs) were maintained in Rictor-null lesions, and nuclear BMI1, a known regulator of the CDKI Cdkn2a, inversely correlated with their expression.Rictor was not required for KRAS-driven ADM following acute pancreatitis, however the inverse correlation between CDKIs and BMI1 was maintained in this system. Treatment of PDX-Cre;KRASG12D/+;Trp53R172H/+ mice with an mTORC1/2 inhibitor delayed tumor formation, and prolonged the survival of mice with late stage PDAC. Knockdown of Rictor in established PDAC cell lines impaired proliferation and anchorage independent growth supporting a role for mTORC2 in fully transformed cells. These data suggest that mTORC2 cooperates with activated KRAS in the initiation and progression of PanIN lesions and is required for the transformation and maintenance of PDAC. My work illustrates phenotypic differences between pancreatic loss of Rictor and PDK1 in the context of KRAS, broadens our understanding of this signaling node and suggests that mTORC2 may potentially be a viable target for PDAC therapies.

Le complexe Arp2/3 génère des réseaux d’actine branchés, qui produisent une forcée de poussée permettant à la cellule de remodeler ses membranes. Le complexe WASH active le complexe Arp2/3 à la surface des endosomes et facilite ainsi la scission membranaire des intermédiaires de transports contenants des récepteurs internalisés tels que les intégrines α5β1. De ce fait, le complexe WASH en favorisant le recyclage des intégrines, joue un rôle crucial dans l’invasion des cellules tumorales durant la progression tumorale. Cependant, le mécanisme d’assemblage du complexe WASH est inconnu. Dans cette étude, nous rapportons l’identification du premier facteur d’assemblage du complexe WASH. Nous avons identifié la protéine HSBP1 grâce à un crible des protéines qui se lient aux formes précurseurs des sous-unités mais plus au complexe une fois assemblé. La reconstitution biochimique et la modélisation moléculaire nous a permis de montrer que HSBP1 est associé avec le précurseur trimérique CCDC53, le dissocie et forme un hétérotrimère qui va éventuellement libérer une forme monomérique de CCDC53 pour l’assemblage du complexe WASH. Le rôle de HSBP1 dans l’assemblage du complexe WASH est conservé. En effet, WASH est déstabilisé dans des cellules mammaires par le knock-down de HSBP1 et dans l’amibe Dictyostelium par le knock-out de HSBP1. La déstabilisation du complexe WASH par le knock-out de HSBP1 phénocopie la déplétion de WASH dans l’amibe Dictyostelium. Dans des cellules humaines de carcinomes mammaires l’inhibition de l’expression de HSBP1 altère le recyclage des intégrines à la membrane plasmidique. Il en résulte des adhésions focales défectueuses et des capacités invasives réduites. De plus, HSBP1 est localisé aux centrosomes et est requis pour la polarité des cellules lors de la migration. Enfin, nous avons trouvé que la surexpression de HSBP1 dans des tumeurs mammaires est associée à une augmentation des niveaux du complexe WASH et à un mauvais pronostic pour les patientes atteintes de cancer du sein. En conclusion, HSBP1 est un facteur d’assemblage conservé qui contrôle les niveaux du complexe WASH<br>The Arp2/3 complex generates branched actin networks, which produces a pushing force that helps the cell to remodel its membranes. The WASH complex activates the Arp2/3 complex at the surface of endosomes and thereby, facilitates the membrane scission of the transport intermediates containing internalized receptors such as α5β1 integrins. Hence, by promoting integrin recycling, the WASH complex plays a crucial role in tumor cell invasion during cancer progression. However, how cells assemble the WASH complex at first is unknown. Here we report the identification of the first assembly factor of the WASH complex. We identified HSBP1 in a proteomics screen for proteins binding to precursor forms of subunits, but not to the fully assembled WASH complex. Through biochemical reconstitution and molecular modeling, we found that HSBP1 associates with the precursor CCDC53 trimer, dissociates it and forms a heterotrimer that will eventually contribute a single CCDC53 molecule to the assembling WASH complex. The role of HSBP1 in WASH complex assembly is well conserved since WASH is similarly destabilized upon HSBP1 knock-down in mammalian cells or upon HSBP1 knock-out in Dictyostelium amoeba. In line with the defective assembly of the WASH complex, the HSBP1 knock-out closely phenocopies WASH knock-out in amoeba. In human mammary carcinoma cells, HSBP1 depletion results in impaired integrin recycling to the plasma membrane leading to the defective development of focal adhesions and reduced invasion abilities. Moreover, HSBP1 was found to localize at the centrosome and was required for the polarization associated with the migration. On the other end, in mammary breast tumors, we found that HSBP1 was often overexpressed and that its overexpression was associated with increased levels of the WASH complex and with poor prognosis for breast cancer patients. Hence, HSBP1 is a conserved assembly factor that controls the levels of the WASH complex

Recent studies suggest adipose tissue plays a critical role in regulating whole body energy homeostasis in both animals and humans. In particular, activating brown adipose tissue (BAT) activity is now appreciated as a potential therapeutic strategy against obesity and metabolic disease. However, the signaling circuits that coordinate nutrient uptake and BAT function are poorly understood. Here, I investigated the role of the nutrient-sensing mTOR signaling pathway in BAT by conditionally deleting Rictor, which encodes an essential component of mTOR Complex 2 (mTORC2) either in brown adipocyte precursors or mature brown adipocytes. In general, inhibiting BAT mTORC2 reduces glucose uptake and de novo lipogenesis pathways while increases lipid uptake and oxidation pathways indicating a switch in fuel utilization. Moreover, several key thermogenic factors (Ucp1, Pgc1α, and Irf4) are elevated in Rictor-deficient BAT, resulting in enhanced thermogenesis. Accordingly, mice with mTORC2 loss in BAT are protected from HFD-induced obesity and metabolic disease at thermoneutrality. In vitro culture experiments further suggest that mTORC2 cell-autonomously regulates the BAT thermogenic program, especially Ucp1 expression, which depends on FoxO1 activity. Mechanistically, mTORC2 appears to inhibit FoxO1 by facilitating its lysine-acetylation but not through the canonical AKT-mediated phosphorylation pathway. Finally, I also provide evidence that β-adrenergic signaling which normally triggers thermogenesis also induces FoxO1 deacetylation in BAT. Based on these data, I propose a model in which mTORC2 functions in BAT as a critical signaling hub for coordinating nutrient uptake, fuel utilization, and thermogenic gene expression. These data provide a foundation for future studies into the mTORC2-FoxO1 signaling axis in different metabolic tissues and physiological conditions.

Recent studies suggest adipose tissue plays a critical role in regulating whole body energy homeostasis in both animals and humans. In particular, activating brown adipose tissue (BAT) activity is now appreciated as a potential therapeutic strategy against obesity and metabolic disease. However, the signaling circuits that coordinate nutrient uptake and BAT function are poorly understood. Here, I investigated the role of the nutrient-sensing mTOR signaling pathway in BAT by conditionally deleting Rictor, which encodes an essential component of mTOR Complex 2 (mTORC2) either in brown adipocyte precursors or mature brown adipocytes. In general, inhibiting BAT mTORC2 reduces glucose uptake and de novo lipogenesis pathways while increases lipid uptake and oxidation pathways indicating a switch in fuel utilization. Moreover, several key thermogenic factors (Ucp1, Pgc1α, and Irf4) are elevated in Rictor-deficient BAT, resulting in enhanced thermogenesis. Accordingly, mice with mTORC2 loss in BAT are protected from HFD-induced obesity and metabolic disease at thermoneutrality. In vitro culture experiments further suggest that mTORC2 cell-autonomously regulates the BAT thermogenic program, especially Ucp1 expression, which depends on FoxO1 activity. Mechanistically, mTORC2 appears to inhibit FoxO1 by facilitating its lysine-acetylation but not through the canonical AKT-mediated phosphorylation pathway. Finally, I also provide evidence that β-adrenergic signaling which normally triggers thermogenesis also induces FoxO1 deacetylation in BAT. Based on these data, I propose a model in which mTORC2 functions in BAT as a critical signaling hub for coordinating nutrient uptake, fuel utilization, and thermogenic gene expression. These data provide a foundation for future studies into the mTORC2-FoxO1 signaling axis in different metabolic tissues and physiological conditions.

Recently, linear ubiquitin assembly complex (LUBAC)-mediated linear ubiquitination has come into focus due to its emerging role in activation of NF-κB in different biological contexts. However, the role of LUBAC in LMP1 signaling leading to NF-κB and interferon regulatory factor 7 (IRF7) activation has not been investigated. We show here that RNF31, the key component of LUBAC, interacts with LMP1 and IRF7 in Epstein-Barr virus (EBV)-transformed cells and that LUBAC stimulates linear ubiquitination of NEMO and IRF7. Consequently, LUBAC is required for LMP1 signaling to full activation of NF-κB but inhibits LMP1-stimulated IRF7 transcriptional activity. The protein levels of RNF31 and LMP1 are correlated in EBV-transformed cells. Knockdown of RNF31 in EBV-transformed IB4 cells by RNA interference negatively regulates the expression of the genes downstream of LMP1 signaling and results in a decrease of cell proliferation. These lines of evidence indicate that LUBAC-mediated linear ubiquitination plays crucial roles in regulating LMP1 signaling and functions. IMPORTANCE We show here that LUBAC-mediated linear ubiquitination is required for LMP1 activation of NF-κB but inhibits LMP1-mediated IRF7 activation. Our findings provide novel mechanisms underlying EBV-mediated oncogenesis and may have a broad impact on IRF7-mediated immune responses.

The diagnose of a mitochondrial disease implies biochemical studies such as the enzymatic activities of the mitochondrial respiratory chain (MRC) and the quantification of the amount of CoQ10 in energetic tissues. Throughout this thesis we have worked on the development of methods to improve these studies in order to get a better diagnostic efficiency in these patients. Blue Native electrophoresis gel allows the study of complex V ATPasa activity and complex I enzymatic activity in cultured fibroblasts, which are not possbile to be studied using standard spectrophotometric methods, becoming good complementary assays. Patients with primary CoQ10 deficiencies improve with CoQ10 treatment. We have developed a technique for the study of the endogenous CoQ10 biosynthesis in cells using non-radioactive isotops that discriminates primary from secondary CoQ10 deficiencies.The implemented methodologies have improved the quality of the analysis test and the diagnose in patiens with a supect of mitochondrial disease or CoQ10 deficiecy<br>El diagnòstic de les malalties mitocondrials inclou estudis bioquímics com ara les activitats enzimàtiques dels complexes de la cadena respiratòria mitocondrial (CRM) i la quantificació del CoQ10 en teixits energètics. En aquesta tesi s’ha treballat en el desenvolupament de mètodes d’estudi per millorar el rendiment diagnòstic dels pacients. La electroforesis en Blue Native-gel permet l’estudi de l’activitat ATPasa del complex V i l’activitat del complex I en fibroblasts, activitats que no es poden determinar mitjançant les tècniques espectrofotomètriques habituals, esdevenint una bona tècnica complementària als estudis espectrofotomètrics. Els pacients amb deficiències primàries de CoQ10 milloren amb tractament amb CoQ10. Hem desenvolupat una tècnica d’estudi de la via de biosíntesi endògena de CoQ10 en cèl•lules mitjançant isòtops no-radioactius que permet discriminar entre deficiències primàries i secundàries de CoQ10. Les metodologies implementades han millorat la qualitat analítica i el diagnòstic en pacients amb sospita de malaltia mitocondrial i/o deficiència de CoQ10

Ce travail de thèse repose sur le développement de méthodes en spectrométrie de masse native et mobilité ionique pour la caractérisation structurale de protéines d’intérêt thérapeutique et de complexes multiprotéiques. L’optimisation fine et conséquente de la préparation d’échantillon et des conditions analytiques ont permis la caractérisation de protéines membranaires solubilisées en milieu détergent, protéines hydrophobes habituellement réfractaires à l’analyse par MS. D’autre part, une nouvelle approche de mobilité ionique appelée Collision Induced Unfolding a été évaluée et mise en place au laboratoire. Elle a permis une caractérisation conformationnelle approfondie et originale de plusieurs formats d’anticorps monoclonaux thérapeutiques. Enfin, les techniques de MS native et de mobilité ionique ont été utilisées pour caractériser des complexes multiprotéiques d’hétérogénéité variable mettant ainsi en lumière leurs avantages et les progrès réalisés dans le domaine de la MS structurale<br>This PhD work focuses on developments in native mass spectrometry and ion mobility methods for the structural characterization of therapeutic proteins and multiprotein complexes. First, careful optimizations of sample preparation and analytical conditions allowed the characterization of membrane proteins, which are hydrophobic proteins difficult to analyze by MS approaches in detergent environment. Then, a new ion mobility-based activation approach called Collision Induced Unfolding has been set up and evaluated. CIU allowed extensive and original conformational characterization of several therapeutic monoclonal antibody formats. Finally, native MS and ion mobility techniques were used for the characterization of heterogeneous multiprotein complexes depicting their benefit when combined to other biophysical techniques for the structural characterization of multiprotein complexes

Le complexe Arp2/3, conservé sur le plan évolutif, joue un rôle central dans la nucléation d’actine branchée, qui entraîne la migration cellulaire, l’endocytose et d’autres processus cellulaire. Récemment, une petite protéine, Arpin, qui inhibe le complexe Arp2/3 au front du lamellipode a été découverte et caractérisée. Sur sa partie C-terminale, Arpin possède un motif acide (A), qui est homologue au motif A des différents NPF (Nucleation Promoting Factor). Il a été prédit qu’Arpin peut se lier à deux sites de liaison au complexe Arp2/3, similaire aux domaines VCA des NPF. Ici, nous utilisons la microscopie électronique de particules uniques pour obtenir une reconstruction 3D du complexe Arp2/3 lié à Arpin, à une résolution de 25 Å. Nous avons montré que la liaison d’Arpin induit la conformation ouverte, standard, du complexe Arp2/3. Nous avons confirmé qu’il y a deux sites de liaison sur le complexe Arp2/3 pour Arpin : un à l’arrière de la sous-unité Arp3, et le second localisé entre les sous-unités Arp2 et ARPC1. La distance entre le complexe Arp2/3 et Arpin (5nm) confirme qu’Arpin interagit avec son partenaire via sa queue acide C-terminale non structurée.Nous avons, ensuite, identifié Tankyrases1/2, comme un nouveau partenaire qui se lie à Arpin, par « pull-down ». De façon intéressante, les sites de liaisons d’Arpin aux Tankyrases et à Arp2/3 se chevauchent. Nous avons, par conséquent, démontré qu’il y a une compétition dose-dépendante entre le domaine ARC4 de Tankyrase1 et le complexe Arp2/3.Pour comprendre les principes de l’interaction entre Arpin et Tankyrases, nous avons créé un mutant d’Arpin (ArpinG218D) qui, in vitro, se lie toujours au complexe Arp2/3, mais plus aux Tankyrases. In vivo, ArpinG218D n’est pas capable d’inhiber le complexe Arp2/3, ce qui suggère que Tankyrase pourrait être nécessaire pour l’interaction entre Arpin et le complexe Arp2/3. Arpin est le facteur responsable du changement de direction des cellules migrantes. Nous avons donc analysé, la migration de cellules MCF10A exprimant soit la forme sauvage d’Arpin (ArpinWT) soit son mutant ArpinG218D en parallèle de la déplétion d’Arpin endogène. Les cellules exprimant ArpinG218D ont une persistance de migration supérieure, similaire à celles déplétées d’Arpin endogène. Nous avons, ainsi, fait l’hypothèse que le mutant ArpinG218D ne peut pas inactiver le complexe Arp2/3 car il n’est pas présent au niveau du lamellipode. Nous avons donc comparé la quantité de protéine d’ArpinWT et d’ArpinG218D dans la fraction membranaire de cellules migrantes. Une différence significative (44%) dans la quantité d’ArpinWT et d’ArpinG218D a confirmé notre hypothèse.Les Tankyrases sont des cibles thérapeutiques dans de nombreux cancers, mais il n’existe pas de modèle structural pour ces protéines grandes et flexibles. Dans ce travail, nous avons, pour la première fois, obtenu deux reconstructions 3D de Tankyrase1 et Tankyrase2 complètes liées à Arpin en utilisant la microscopie électronique de particules uniques. La résolution obtenue (27 Å) a été suffisante pour détecter un changement de conformation dramatique des domaines SAM et PARP de Tankyrase après fixation d’Arpin. Dans notre reconstruction, trois molécules d’Arpin se lient aux domaines ARC1, ARC4 et ARC5 de Tankyrase1. ARC5 a été montré pour être la partie le plus flexible de l’ensemble des domaines ARC.Grâce aux données que nous avons obtenues, nous avons suggéré un modèle de régulation de l’activité d’Arpin par les Tankyrases. Selon notre modèle, les Tankyrases se lient à Arpin dans le cytoplasme, changent sa conformation et amènent Arpin au niveau de la membrane dans le lamellipode. Traduisant les signaux extracellulaires, la GTPase Rac active Arpin, qui séquentiellement inactive le complexe Arp2/3, tandis que les Tankyrases sont libérées<br>The evolutionarily conserved Arp2/3 complex plays a central role in nucleating the branched actin filament arrays that drive cell migration, endocytosis, and other processes. Recently, an inactivator of the Arp2/3 complex at the lamellipodium tip, a small protein, Arpin, was discovered and characterized. On its C-terminus, Arpin possesses an acidic (A) motif, which is homologous to the A-motif of various Nucleation Promoting Factors (NPFs). It was predicted that Arpin can bind at two binding sites to the Arp2/3 complex, similar to VCA domains of NPFs. Here, we used single particle electron microscopy to obtain a 3D reconstruction of the Arp2/3 complex bound to Arpin at a 25Å resolution. We showed that the binding of Arpin causes the standard open conformational of the Arp2/3 complex. We confirmed that there are two binding sites on the Arp2/3 complex for Arpin: one on the back of the Arp3 subunit, and the second is located between Arp2 and ARPC1 subunits. The distance between the Arp2/3 complex and Arpin (5 nm) supports the view that Arpin interacts with its partner via its unstructured C-terminal acidic tail.Next, using the pull-down assay, we identified the new Arpin binding partners, Tankyrases1/2. Interestingly, Tankyrases and the Arp2/3 complex possess overlapping amino acid sequences at Arpin binding sites. Hence, we demonstrated a competition between the ARC4 domain of Tankyrase1 and the Arp2/3 complex in a dose-dependent manner.To understand the principles of Tankyrases-Arpin interaction, we created a mutant Arpin (ArpinG218D) that lacks its ability to interact with Tankyrases, but not with the Arp2/3 complex in vitro. Interestingly, ArpinG218D was not able to inhibit the Arp2/3 complex in vivo, suggesting that Tankyrase may be necessary for Arpin-Arp2/3 complex interaction. Arpin is the turning factor of migrating cells, so we performed a migration analysis of MCF10-A cells expressing either wild type Arpin (ArpinWT) or mutant ArpinG218D in parallel with the depletion of endogenous Arpin. Cells expressing ArpinG218D had higher directional persistence, similar to the cells where the endogenous Arpin was knocked down. Thus, we suggested that mutant ArpinG218D cannot inactivate the Arp2/3 complex since it is not present at the lamellipodial tip. We compared the amount of protein for both ArpinWT and ArpinG218D in the membrane fraction of the migrating cells. A significant difference (44%) in the amount of ArpinWT and Arpin G218D was consistent with our hypothesis.Tankyrases are therapeutic targets in a variety of cancers, but currently there is no structural model available for these large and flexible proteins. In this work, we obtained for the first time two 3D reconstructions of full-length Tankyrase1 and Tankyrase1 bound to Arpin using single particle electron microscopy. The achieved resolution (27Å) was enough to detect a dramatic conformational change in Tankyrase SAM and PARP domains upon binding of Arpin molecules. In our reconstruction, three Arpins were bound to the ARC1, ARC4 and ARC5 domains of Tankyrase1. ARC5 was shown to be the most flexible part of the ARC cluster.Based on the obtained data, we suggested a model of regulation of the activity of Arpin by Tankyrases. According to our model, Tankyrases bind Arpin in the cytoplasm, change their conformational state and bring Arpin closer to the membrane in the lamellipodia. Deciphering the extracellular signals, Rac GTPase activates Arpin, which sequentially inactivates the Arp2/3 complex, while Tankyrases are released

Les ribonucléases et les hélicases à ARN sont des acteurs clé du métabolisme des ARN et jouent donc des rôles cruciaux pour la régulation de l'expression des gènes. Peu de données sont connues concernant ce métabolisme chez les Archées, le troisième domaine du vivant. L'équipe dans laquelle j'ai effectué mes travaux de thèse s'intéresse au métabolisme de l'ARN chez les archées et plus particulièrement aux ribonucléases ß-CASP. Dans ce contexte, nous focalisons nos études sur la compréhension physiologique que pourrait jouer les ribonucléases ß-CASP aCPSF1 et aRNase J, orthologue respectivement du facteur de terminaison de la transcription eucaryotes CPSF-73 et RNase J bactérienne. Par analogie avec CPSF-73 et RNase J, qui font partie de complexes multi-protéiques, des indices sur les fonctions des homologues archéens de ces ribonucléases pourraient provenir de l'identification des complexes autour de aCPSF1 et aRNase J. Utilisant des extraits de Pyrococcus abyssi et les protéines recombinantes aCPSF1 et aRNase J comme appâts, nous avons identifié que aRNase J fait partie d'un réseau d'interaction incluant une hélicase de la famille des Ski2-like (ASH-Ski2). En parallèle, des fractionnements d'extrait de P. abyssi sur gradient de saccharose par ultracentrifugation indiquent que aRNase J et ASH-Ski2 sont présentes toutes deux dans les fractions de haut poids moléculaires avec les sous-unités du ribosome et ceux de l'exosome. Nous avons aussi démontré une interaction stable entre aRNase J et ASH-Ski2 ainsi que des motifs impliquées dans cette interaction par des expériences de co- purification par chromatographie d'affinité. De plus, les caractérisations biochimiques de ASH-Ski2 indiquent que cette protéine possède une activité d'hydrolyse de l'ATP dépendant de la présence d'acides nucléiques. ASH-Ski2 possède de plus la capacité d'hybridation et de déroulement de deux brins d'acides nucléiques en présence d'ATP. A notre connaissance, nos résultats sont les premiers à indiquer un complexe contenant une ribonucléase et d'une hélicase à ARN Ski2-like chez les archées. De manière intriguent, aRNase J est orthologue de la RNase J bactérienne et ASH-Ski2 des hélicases Ski2-like des eucaryotes. Cela démontre que les Archées pourraient posséder un système composite impliqué dans le métabolisme des ARN partageant des caractéristiques bactériens et eucaryotes. Ces résultats mettent en lumière l'avantage de l'étude des Archées pour la compréhension des mécanismes moléculaires et évolutives des processus fondamentaux des trois domaines du vivant<br>Ribonucleases and RNA helicases are the main actors of RNA processing and have a critical role in gene expression regulation. Little is known about this process in Archaea. Our group focuses in RNA metabolism in Archaea involving ß-CASP ribonucleases. Recently, we published phylogenomic and experimental work demonstrating that archaeal ß-CASP proteins, aCFSF1 and aRNase J, are highly conserved ribonucleases in Archaea. Archaeal aCPSF1, an ortholog of the eukaryal transcription termination factor CPSF73, is ubiquitous in Archaea suggesting an essential conserved function. Archaeal aRNase J, an ortholog of the bacterial ribonuclease RNase J, is conserved through a major phylum of the Archaea, the Euryarchaeota. These findings suggest that the role of these enzymes in RNA processing can be reminiscent of ancient functions that had arisen early in evolution. We now want to focus on understanding the physiological role of aCPSF1 and aRNase J with the hyperthermophilic euryarchaeal Pyrococcus abyssi as model. By analogy to eukaryal CPSF73 and bacterial RNase J, which are part of multiprotein complexes, clues to the function of the archaeal ß-CASP homologs might come from the identification of archaeal multiprotein complex(es) containing aCPSF1 and aRNase J orthologs. Using P. abyssi cell extracts and recombinant aCPSF1 or aRNase J as bait, we have found that aRNase J is a part of protein interaction networks that include Ski2-like RNA helicase (ASH-Ski2). In parallel, fractionation of P. abyssi whole cell extracts in sucrose gradient by ultracentrifugation shows that aRNase J and ASH-Ski2 are present in high sedimentation fractions with ribosomal and exosome sub-units. We also demonstrate a direct interaction of aRNase J with ASH-Ski2 by co-purification affinity chromatography experiments and identify motifs that potentially involve in this interaction. Biochemical characterization of ASH-Ski2 demonstrates a nucleic dependant ATPase activity. ASH-Ski2 also possesses annealing and unwinding activities in presence of ATP. To our knowledge, our results are the first experimental indications of interacting of a complex containing ribonuclease and RNA helicase-like proteins in Archaea. Remarkably, aRNase J is an orthologue of the bacterial RNase J and ASH-Ski2 is an orthologue of the eukaryotic Ski2-like family proteins. This shows that Archaea might possess a composite RNA processing system sharing both eukaryal and bacterial features. This highlights the advantage of an archaeal model to gain further mechanistic and evolutionary information of fundamental processes across the three domains of life

Tesis presentada a la Universidad de Chile para optar al grado de Magíster en Bioquímica, área de especialización Proteínas Recombinantes, y Memoria para optar al título profesional de Bioquímico<br>La regulación de la expresión génica es un evento crucial para el músculo esquelético, ya que determina la homeostasis y la plasticidad muscular, permitiendo la remodelación y transformación del músculo para adaptarse a distintos estímulos. La actividad eléctrica regula la expresión de diferentes genes del músculo esquelético por medio de un proceso conocido como “Acoplamiento Excitación-Transcripción”. Se ha demostrado recientemente que el ATP extracelular es un mediador esencial entre la estimulación eléctrica, la liberación transitoria de calcio intracelular y la expresión de genes en el músculo esquelético. Considerando que la regulación de la expresión génica esta mediada por la despolarización de la membrana plasmática, la consecuente liberación de ATP y la activación de vías de señalización intracelulares, este trabajo propone la existencia de un complejo multiproteico en la membrana del túbulo-T, que favorecería la adecuada coordinación entre el sensor de voltaje (Receptor de dihidropiridina, DHPR), el canal Panexina-1 (Panx1, liberador de ATP), receptores purinérgicos (P2Y), otras proteínas de membrana como Distrofina y otras moléculas intracelulares involucradas en la transducción de esta señal, como PI3Kγ. Actualmente se sabe que diversos procesos de señalización celular son regulados por complejos multiproteicos, un conjunto de proteínas asociadas para coordinar los distintos pasos en una vía de transducción de señal. Trabajo previo del laboratorio ha demostrado que DHPR interacciona con el canal de Panx1. El objetivo general de esta tesis fue identificar nuevos componentes del complejo multiproteico que regula el Acoplamiento Excitación-Transcripción, en células de músculo esquelético L6 que expresan el canal Panexina-1 recombinante y en preparación de triadas de músculo esquelético de ratón, mediante experimentos de co-inmunoprecipitación, electroforesis bidimensional BlueNative, inmunofluorescencia indirecta y ensayos de ligación por proximidad in situ. Los resultados obtenidos mostraron que el canal Panx1 interactúa con DHPR y P2Y2 en la membrana del túbulo-T. Además, por medio de co-inmunoprecipitación y ensayos de ligación por proximidad, demostramos que las proteínas Distrofina, Caveolina-3 y PI3Kγ también forman parte del complejo multiproteico que regularía el Acoplamiento Excitación- Transcripción, en mioblastos y miotubos de células L6 que sobre-expresan el canal Panx1 recombinante. Los análisis de colocalización realizados en miotubos de células L6-Panx1 mostraron una asociación entre Panx1-DHPR, Panx1-PI3K y Cav-3-Panx1, considerando coeficientes de Manders superiores al 50% de colocalización. Al resolver triadas de ratón usando la técnica de electroforesis bidimensional BlueNative SDS-PAGE, se demostró la presencia de un complejo multiproteico que contiene a las proteínas Panx1, Cav-3 y DHPR. Además, se logró identificar DHPR a partir de complejos aislados mediante la primera dimensión del BlueNative, mediante espectrometría de masas. Este estudio aporta nueva información respecto de cómo se organizan las proteínas relacionadas con la plasticidad muscular, que participan en el al Acoplamiento Excitación- Transcripción en el músculo esquelético. El entendimiento de este fenómeno tiene importantes implicancias en procesos fisiológicos, como la respuesta del músculo frente al ejercicio, y también con procesos patológicos que afectan al músculo esquelético como la sarcopenia y las distrofias musculares. Los resultados obtenidos en esta Tesis permiten abrir nuevas áreas de investigación relacionadas con el estudio de la relación entre el acoplamiento Excitación-Transcripción y la fisiopatología musculoesquelética<br>Gene expression regulation is a crucial event for skeletal muscle, because determines muscle homeostasis and plasticity that allows muscle remodeling for adapting to environmental demands. Electrical activity regulates the expression of an important number of skeletal muscle genes in a process known as “Excitation-Transcription Coupling”. We have previously demonstrated that extracellular ATP is a relevant mediator between electrical stimulation, intracellular calcium transients and gene expression in skeletal muscle cells. Considering gene expression regulation is mediated by sarcolemma depolarization, ATP release and specific signaling pathways activation, this work propose the assembly of a multiprotein complex in T-tubules, allowing the proper coordination between the voltage sensor (dihydropyridine receptor, DHPR), the pannexin channel (Panx1; ATP release conduit), the P2Y nucleotide receptors, other membrane proteins such as Dystrophin, and several intracellular molecules involved in signal transduction, such as PI3Kγ. It is currently known that several cell signaling processes are mediated by multiprotein complexes, a cluster of proteins associated to achieve coordinated steps in a transduction pathway. Previous work in our laboratory has shown a likely protein-protein interaction between Panx1 and DHPR. The general aim of this thesis was to identify new molecular components of the multiprotein complex associated to Excitation-Transcription Coupling, in L6 skeletal muscle cells which stably express a recombinant Panx1, and in mouse triads preparation. We used co-immunoprecipitation, two-dimension Blue Native electrophoresis, indirect immunofluorescence and proximity ligation in situ assays. Our results showed a well-defined protein-protein interaction between the Panx1 channel, DHPR and P2Y2 receptor. Moreover, co-immunoprecipitation and Proximity ligation assay results, identified the proteins Dystrophin, Caveolin-3 and PI3Kγ as participants of the multiprotein complex involved in Excitation-Transcription coupling, both in myoblasts and myotubes of L6 skeletal muscle cell line, stably expressing recombinant Panx1 protein. The co-localization assays showed a well-defined association between Panx1-DHPR, Panx1- PI3K and Panx1-Cav-3, considering Manders’s coefficients higher than 50%. Triads samples resolution using BlueNative SDS-PAGE electrophoresis, evidenced a multiprotein complex containing DHPR, Panx1 and Cav-3. Furthermore, we identified DHPR by mass spectrometry, by complex isolation from 1D BlueNative gels. This study provides new information about the organization of the proteins related to muscle plasticity, involved in the Excitation-Transcription Coupling in skeletal muscles. The understanding of this process has relevant implications in physiological processes, such as the muscle response to exercise, and in pathological processes like sarcopenia and muscular dystrophies. Results emanated from this Thesis will allow opening new research areas related to clarify the association between Excitation-Transcription coupling and skeletal muscle physiopathology<br>Fondecyt Regular Nº 1110467; Fondecyt de Iniciación N° 11100454; Proyecto Anillo ACT N° 1111; Beca CONICYT N°22120686

Les objectifs de mes travaux de thèse étaient de développer de nouvelles méthodes d’identification, de caractérisation et de quantification de protéines, mieux adaptées à la diversité des études en protéomique, ce dont la biologie a besoin aujourd’hui. L’analyse protéomique par spectrométrie de masse est apparue comme un outil précieux et pertinent pour évaluer la qualité de l’isolement d’un complexe spécifique, et pour guider les biologistes dans les choix de la stratégie à adopter. La stratégie de marquage de N-terminomique développée a permis de caractériser un processus de maturation biologique en déterminant précisément les sites d’activation de la protéine Perséphone par marquage spécifique des extrémités N-terminales. Ce travail a permis d’élucider un nouveau mécanisme fin de régulation dans l’immunité innée chez la drosophile. De nouveaux modes de marquages ont été mis au point et les familles chimiques des réactifs de marquage étudiés permettront d’adapter au mieux les études de quantifications protéomiques à la nature et aux contraintes des études biologiques à mener<br>The aim of this work was to develop new methods for the identification, characterization and quantification of proteins best suited to a large diversity of proteomics studies, which is nowadays essential to biology. Our work has shown that proteomic analysis based on mass spectrometry can be a valuable and relevant tool to evaluate the isolation strategy efficiency set up for a specific complex and thus guide the biologists in their choice. The N-terminomic labeling strategy developed allowed us to describe a biological maturation process by determining precisely the Persephone protein activation sites using specific labeling of the successively generated N-terminal extremities. This work allowed elucidating a new regulation mechanism in the Drosophila innate immunity system. New chemical labeling reagents to target specific amino acids (cysteine, tyrosine and tryptophan) have been set up for fast mass-spectrometry based proteomics. These labeling strategies combined with proteomic tools will allow developing a robust and quantitative approach essential for biological studies

Environ 30% des CDS prédits d'un génome code pour des protéines de fonction inconnue ou hypothétiques. La compréhension du rôle de ces protéines est donc l'un des grands challenges de la communauté scientifique.L'objectif principal de cette thèse est de comprendre la fonction de six protéines de fonction inconnue spécifiques de l'anaérobiose formant un complexe, appelé complexe ORP chez Desulfovibrio vulgaris Hildenborough (DvH). Ce système est répandu dans de nombreuses espèces anaérobies, et certaines de ses protéines possèdent des homologies significatives avec des protéines impliquées dans la division cellulaire.Des outils de microscopie dédiés à l'anaérobiose ont été développés au cours de cette thèse et ont permis, pour la première fois, l'observation du cycle cellulaire de DvH. L'étude de l'effet de l'oxygène à l'échelle de la cellule unique a montré une inhibition réversible de la division cellulaire en présence d'oxygène révélant une nouvelle stratégie impliquée dans l'aérotolérance de DvH.Chez DvH, le complexe ORP est codé par des gènes organisés en deux opérons divergents, orp1 et orp2, dont la transcription est gouvernée par l'ARN polymérase sigma54, le facteur de transcription IHF et l'activateur de transcription DVU2106.La diminution de la quantité de complexe ORP conduit à une hétérogénéité de la taille des cellules en accord avec un rôle potentiel du complexe dans le contrôle de la division cellulaire. Alors que l'absence de certaines protéines ORP n'affecte pas de manière significative la division de la bactérie en anaérobiose, la protéine DVU2109 présente une localisation dynamique au cours du cycle cellulaire et semble être essentielle chez DvH<br>Up to now, approximately 30% of the predicted CDS in genomes encode for hypothetical or unknown function proteins. Understanding the role and the function of these proteins is now a major challenge for the scientific community.The main objective of this thesis is to determine the function of six proteins of unknown function specific of anaerobiosis and able to forming a multiprotein complex in Desulfovibrio vulgaris Hildenborough (DvH), named the ORP complex. This system is widely found in many anaerobic microorganisms, and some proteins of this system have significant homologies with proteins involved in cell division.Tools for microscopy in anaerobiosis have been developed during this thesis and have allowed observation, for the first time, of a complete DvH cell cycle. The study of oxygen effect on DvH at a single cell level has showed a reversible inhibition of cell division during oxygen exposure revealing a new strategy involved in DvH aerotolerance.In DvH, the ORP complex is encoding by genes organized in two divergent operons, orp1 and orp2, whose transcription is governed by sigma 54 RNA polymerase, the transcription factor IHF and the transcriptional regulator DVU2106. The decreased in the amount of ORP complex leads to heterogeneity of the cell size in accordance with a potential role of this complex in the spatio-temporal control of DvH cell division. While the absence of the majority of ORP proteins doesn't significantly affect DvH division in anaerobic conditions, the protein DVU2109 has a dynamic location during cell cycle and appears to be essential in the cell

Sexually reproducing organisms depend on meiosis for the generation of haploid, genetically diverse gametes to maintain genome stability and the potential to adapt to changing environments. Haploidization is achieved through two successive rounds of cell division after a single initial pre-meiotic DNA replication. Meiosis I segregates the homologous chromosomes, followed by the segregation of the sister chromatids in meiosis II. Genetic diversity is achieved through the process of recombination that de-scribes the exchange of genetic material between the maternal and paternal homolog. Recombination and the initial steps of haploidization are executed already early on in prophase I. Both essential processes depend on a variety of multiprotein complexes, such as the linker of nucleo- and cytoplasm (LINC) complex and the synaptonemal complex (SC). The structure of multiprotein complexes is adjusted according to their function, environment, and the forces they are subjected to. Coiled-coil domains typical in load-bearing proteins characterize the meiotic mechanotransducing LINC complexes. SCs resemble ladder-like structures that are highly conserved amongst eukaryotes, while the primary sequence of the proteins that form the complex display very little if any sequence homology. Despite the apparent significance of the structure to their function, little quantitative and topological data existed on the LINC complexes and the SC within their morphological context prior to the present work. Here, the molecular architecture of the meiotic telomere attachment site where LINC complexes reside and the SC have been analyzed in depth, mainly on the basis of electron microscope tomography derived 3D models complemented by super-resolution light microscopic acquisitions of the respective protein components<br>Sich sexuell fortpflanzende Organismen sind auf die Meiose angewiesen, um haploide, genetisch vielfältige Keimzellen zu erzeugen, die die Stabilität des Genoms und die Fähigkeit zur Anpassung an sich verändernde Umgebungen erhalten. Die Haploidisierung wird durch zwei aufeinanderfolgende Runden der Zellteilung nach einer einzigen anfänglichen prä-meiotischen DNA Replikation erreicht. In der Meiose I werden die homologen Chromosomen getrennt, gefolgt von der Trennung der Schwesterchromatiden während der Meiose II. Genetische Diversität wird durch den Prozess der Rekombination erreicht, der den Austausch von genetischem Material zwischen den mütterlichen und väterlichen Homologen beschreibt. Die Rekombination und die ersten Schritte der Haploidisierung werden bereits früh in der Prophase I durchgeführt. Beide essentiellen Prozesse hängen von einer Vielzahl von Multiproteinkomplexen ab, wie z.B. dem Linker of Nucleo- and Cytoplasm (LINC)-Komplex und dem synaptonemalen Komplex (SC). Die Struktur von Multiproteinkomplexen wird je nach ihrer Funktion, ihrer Umgebung und den Kräften, denen sie ausgesetzt sind, angepasst. Coiled-coil-Domänen, die für tragende Proteine typisch sind, charakterisieren die meiotischen, mechanotransduzierenden LINC-Komplexe. SCs ähneln leiterähnlichen Strukturen, die unter Eukaryonten hoch konserviert sind, während die Primärsequenz der Proteine, die den Komplex bilden, sehr wenig bis gar keine Sequenzhomologie aufweist. Trotz der offensichtlichen Bedeutung der Struktur für ihre Funktion gab es vor der vorliegenden Arbeit nur wenige quantitative und topologische Daten über die LINC Komplexe und den SC in ihrem morphologischen Kontext. Hier wurde die molekulare Architektur der Telomeranheftungsstellen, an denen sich die LINC-Komplexe befinden, und die des SCs eingehend analysiert, hauptsächlich auf der Grundlage von auf der Elektronenmikroskop-Tomographie basierenden 3D-Modellen, ergänzt durch hochauflösende lichtmikroskopische Aufnahmen der jeweiligen Proteinkomponenten

碩士<br>國立嘉義大學<br>生物科技研究所<br>90<br>Abstract MNDA receptor ( N-methyl-D-aspartate receptor ) associated protein is a large protein. This group of protein forms respectively receptor, adaptor, signaling, cytoskeletal and so on. The ion channel of NMDA receptor may control their kinases, phosphatase and other enzymes. Furthermore, they also control AMPA receptors ( α-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid receptor ), apine cytoskeletal chantes, translation, transcription, as well as other changes. Therefore, the more we understand about the biochemical characteristics of this group of proteins, the more we are clear about their correlations. Former research pointed out that, by using fresh pig brains as the research material, Triton X-114/KCl might dissolve AMPA receptor, meanwhile, NMDA receptor could not easily be dissolved with Triton X-114/KC1. The objective of our research is to establish a system that effectively isolates and purifies NMDA receptor and its associated protein, and analyzes their biochemical characteristics. We used fresh mouse’s brain as this research’s material. First of all, we made and prepared it into crude synaptosome, and then we used Triton X-114/KC1 ( including not containing SDS, containing 0.25% of SDS, and containing 0.5% of SDS ) to carry out the phase separation. There are precipitations that under not containing SDS, but less and less, even no precipitation that under 0.25%, 0.5% of SDS. By using 1-dimensional polyacrylamide gel electrophoresis ( 1D-PAGE-electrophoresis ) and Western blotting analysis, the result showed that NMDA receptor and its associated protein were also dissolved with Triton X-114/KC1 and SDS. At the same time, we also found some interesting phenomena from the result of silver stain. Under different conditions, there were significant changes in the distribution of proteins in aqueous phase and detergent phase. Finally, we used sucrose gradient centrifugation, and we found that the basic structure of NMDA receptor associated protein with the existence of 0.5% SDS was NR1+NR2+CaMKII+PSD95.

Η κινάση εστιακής προσκόλλησης (FAK) είναι μια πρωτεϊνική κινάση τυροσίνης (nRPTK) με κυτταροπλασματική κατανομή στην περιφέρεια του κυττάρου. Εντοπίζεται κυρίως σε περιοχές του κυττάρου γνωστές ως εστίες προσκόλλησης, με τις οποίες το κύτταρο προσκολλάται στην εξωκυτταρική ύλη. Συμμετέχει σε σημαντικές κυτταρικές διεργασίες όπως στην κυτταρική κίνηση και μετανάστευση, στον κυτταρικό πολλαπλασιασμό, στην κυτταρική επιβίωση και απόπτωση. Η FAK ενεργοποιείται από πολλά ερεθίσματα που μπορούν να επάγουν φωσφορυλίωση της σε αμινοξέα τυροσίνης (Υ397, Υ576, Υ577, Υ861, Υ925) όπως για παράδειγμα αυξητικοί παράγοντες, νευροπεπτίδια, παράγοντες που ενεργοποιούν υποδοχείς συνδεδεμένους με G-πρωτεΐνες και μηχανικά ερεθίσματα αλλά κυρίως μετά από τη διέγερση των ιντεγκρινικών υποδοχέων των κυττάρων. Ο ρόλος της FAK στην μεταγωγή μηνυμάτων, στο πλαίσιο της κυτταρικής επικοινωνίας είναι διττός: δρα ως κινάση φωσφορυλιώνοντας τα υποστρώματα της αλλά και ως πρωτεΐνη συνδετήρας (adaptor protein) δημιουργώντας πολυπρωτεϊνικά σηματοδοτικά σύμπλοκα. Δεδομένης, λοιπόν, της ιδιαίτερης φύσης του μορίου, η FAK θα μπορούσε να χαρακτηριστεί ως ενεργοποιούμενη πρωτεΐνη ικρίωμα (activable scaffold protein). Στην παρούσα εργασία μελετήσαμε την ενεργοποίηση της FAK κατά την κυτταροφαγία του βακτηρίου E. coli. Έτσι, χρησιμοποιήθηκαν φαρμακολογικοί αναστολείς για να ανιχνευθεί η συμμετοχή τελεστών της μεταγωγής σημάτων στην ενεργοποίηση της FAK. Επιπλέον, διερευνήθηκε με ανοσοκατακρημνίσεις η συμπλοκοποίηση της FAK με πρωτεΐνες-κλειδιά σημαντικών κυτταρικών μονοπατιών σε κύτταρα που βρίσκονταν σε εναιώρημα.<br>Cells respond to extracellular stimuli with the recruitment of multiple cytoskeletal and regulatory proteins, which form specialized complexes. These complexes are usually involved in the promotion of integrin-mediated signals to the nucleus. In this study, we investigated whether any signal transduction complexes are constitutively present, in Medfly hemocyte suspension, in the absence of external stimuli. Hemocytes from the 3rd instar larvae were isolated and protein crude extracts were prepared. In hemocyte lysates, the presence of FAK (focal adhesion kinase), Integrin β1 and the adaptor protein Paxillin was identified with immunoprecipitation and immunoblot analysis. The presence of these proteins was also confirmed with immunofluorescence microscopy, in attached hemocytes on glass slides. Co-immunoprecipitation with FAK and immunoblot analysis with anti-Paxillin, anti-tubulin, anti-actin and anti-ERK revealed the complex formation of FAK with Paxillin, Tubulin, Actin and ERK in hemocyte suspensions. The profiles of this complex and of each one of these proteins, separately, varies, during development and phagocytosis of E.coli. Consequently, it was demonstrated that FAK forms complex with cytoskeletal proteins like paxillin, tubulin, actin and signalling proteins such as ERK, in Medfly hemocytes, without the influence of any extracellular stimuli.

Dissertação de mestrado em Genética Molecular<br>Colorectal Cancer (CRC) is a heterogeneous complex disease, which is the third most commonly diagnosed cancer worldwide. Despite the intensive follow-up and the novel therapeutic options for CRC patients, it remains as one of the most leading causes of cancerrelated deaths. CRC carcinogenesis results mainly from the serrated or from the adenomacarcinoma pathways, being associated with several mutations in key molecules. KRAS mutations are a very frequent event present in CRC being the hotspot mutations the following: KRASG13D, KRASG12D and KRASG12V. These mutations can lead to constitutively activation of KRAS proteins, which contribute to colorectal tumorigenesis, and no specific inhibitors are available what constitutes a clinical problem to overcome. Galectin-3 (Gal-3) belongs to galectins family and its function depends on its subcellular localization. Its abnormal localization is common in many types of human cancers, including CRC, and is correlated with cancer cell invasion and tumor angiogenesis. Recent studies shown that Gal-3 overexpression is associated with increased KRAS signal output, leading to increased cell proliferation, survival and migration. However, the interactions between Gal-3 and active KRAS are not fully understood. On its turn, p16INK4a is a tumor suppressor protein, G1 cyclin-dependent kinase (CDK) inhibitor which loss occurs during malignant transformation. Since overexpression of KRAS can be induced by loss of p16INK4a the latter has been appointed with a crucial role in CRC carcinogenesis. In the present project, we aimed to study the role of KRAS in the regulation of KRAS/Galectin- 3/p16INK4a triple axis in CRC and the impact of the complex in CRC invasion and invasionassociated activities. Our results demonstrated for the first time using normal colon and CRC cells, that KRAS/Galectin-3/p16INK4a interact, forming a multiprotein complex which showed a feedback loop regulation. Moreover, we provided evidences that this complex might be a new mechanism of inactivation of the tumor suppressor gene p16INK4a by forcing its re-localization from the nucleus to the cytoplasm. Our data also identified KRAS and Gal-3 as important players in CRC migration and invasion. This work opens a new field of research, as understanding the role of KRAS/Galectin- 3/p16INK4a complex regulation on colorectal carcinogenesis might have relevant therapeutic implications.<br>O cancro colorretal é uma doença heterogénea complexa, que corresponde ao terceiro cancro mais frequentemente diagnosticado no mundo. Apesar do acompanhamento intensivo dos pacientes e dos últimos avanços terapêuticos, é ainda uma das principais causas de morte associadas a cancro. O seu processo de carcinogénese resulta principalmente das vias serreada e adenoma-carcinoma, estando associado a mutações em moléculas chave. As mutações do gene KRAS são eventos muito frequentes no cancro colorretal sendo as mutações mais comuns as seguintes: KRASG13D, KRASG12D e KRASG12V. Estas mutações podem levar à ativação constitutiva das proteínas KRAS, contribuindo para a tumorigénese, não havendo inibidores específicos do KRAS o que é um problema clínico que precisa de resolução. A Galectina-3 pertence à família das galectinas e a sua função depende da sua localização subcelular. A sua localização anormal é frequente em vários tipos de cancros, incluindo no cancro colorretal, e está relacionada com a invasão e angiogénese do tumor. Estudos recentes demonstraram que a sobreexpressão da proteína Gal-3 está associada ao aumento da sinalização mediada pelo KRAS, resultando no acréscimo da proliferação, sobrevivência e migração celulares. No entanto, as interações entre a Galectina-3 e a proteína KRAS ativada não estão ainda completamente compreendidas. Por sua vez, a p16INK4a é uma proteína supressora de tumores, inibidora G1 da cinase dependente de ciclina cuja perda ocorre frequentemente durante a transformação maligna dos tumores. Uma vez que a sobreexpressão da proteína KRAS pode ser induzida pela perda da expressão da p16INK4a, pensa-se que a última tenha também um papel muito importante na carcinogénese colorretal. No presente projeto, pretendemos estudar o papel da proteína KRAS na regulação do eixo KRAS/Galectin-3/p16INK4a no cancro colorretal e o impacto deste complexo na invasão e nas atividades associadas à invasão tumoral. Os nossos estudos, utilizando linhas celulares colorretais normais e cancerígenas, demonstraram, pela primeira vez, que as proteínas KRAS/Galectin-3/p16INK4a interagem entre si formando um complexo de regulação recíproca. Apresentamos ainda, evidências de que este complexo pode ser um novo mecanismo de inativação da proteína supressora tumoral p16INK4a, por forçar a sua relocalização do núcleo para o citoplasma. Os nossos dados também identificaram o KRAS e a Galectina-3 como intervenientes importantes na migração e invasão das células colorretais. Este trabalho abre novas perspetivas de investigação sobre o papel da regulação do complexo KRAS/Galectin-3/p16INK4a na carcinogénese colorretal que poderá ter implicações terapêuticas relevantes.<br>Fundação para a Ciência e Tecnologia (FCT) - Projeto PEst-OE/BIA/UI4050/2014, ao projeto European Marie Curie Initial Training Networks (ITN): FP7-PEOPLE-2012-ITN: “GLYCOPHARM: The sugar code: from (bio)chemical concept to clinics” e ao Norte 2020 pelo financiamento

A cellular pre-mRNA undergoes various post-transcriptional processing events, including capping, splicing and polyadenylation prior to nuclear export. Splicing is particularly important for mRNA nuclear export as two distinct multi-protein complexes, known as human TREX (hTREX) and the exon-junction complex (EJC), are recruited to the mRNA in a splicing-dependent manner. In contrast, a number of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic mRNAs lack introns and are exported by the virus-encoded ORF57 protein. Herein we show that ORF57 binds to intronless viral mRNAs and functions to recruit the complete hTREX complex, but not the EJC, in order assemble an export component viral ribonucleoprotein particle (vRNP). The formation of this vRNP is mediated by a direct interaction between ORF57 and the hTREX export adapter protein, Aly. Aly in turn interacts directly with the DEAD-box protein UAP56, which functions as a bridge to recruit the remaining hTREX proteins to the complex. Moreover, we show that a point mutation in ORF57 which disrupts the ORF57-Aly interaction leads to a failure in the ORF57-mediated recruitment of the entire hTREX complex to the intronless viral mRNA and inhibits the mRNAs subsequent nuclear export and virus replication. Furthermore, we have utilised a trans-dominant Aly mutant to prevent the assembly of the complete ORF57-hTREX complex; this results in a vRNP consisting of viral mRNA bound to ORF57, Aly and the nuclear export factor, TAP. Strikingly, although both the export adapter Aly and the export factor TAP were present on the viral mRNP, a dramatic decrease in intronless viral mRNA export and virus replication was observed in the absence of the remaining hTREX components (UAP56 and hTHO-complex). Together, these data provide the first direct evidence that the complete hTREX complex is essential for the export of KSHV intronless mRNAs and infectious virus production.

Hyperphosphorylated tau plays an important role in the formation of neurofibrillary tangles in brains of patients with Alzheimer's disease (AD) and related tauopathies and is a crucial factor in the pathogenesis of these disorders. Though diverse kinases have been implicated in tau phosphorylation, protein phosphatase 2A (PP2A) seems to be the major tau phosphatase. Using murine primary neurons from wild-type and human tau transgenic mice, we show that the antidiabetic drug metformin induces PP2A activity and reduces tau phosphorylation at PP2A-dependent epitopes in vitro and in vivo. This tau dephosphorylating potency can be blocked entirely by the PP2A inhibitors okadaic acid and fostriecin, confirming that PP2A is an important mediator of the observed effects. Surprisingly, metformin effects on PP2A activity and tau phosphorylation seem to be independent of AMPK activation, because in our experiments (i) metformin induces PP2A activity before and at lower levels than AMPK activity and (ii) the AMPK activator AICAR does not influence the phosphorylation of tau at the sites analyzed. Affinity chromatography and immunoprecipitation experiments together with PP2A activity assays indicate that metformin interferes with the association of the catalytic subunit of PP2A (PP2Ac) to the so-called MID1-alpha4 protein complex, which regulates the degradation of PP2Ac and thereby influences PP2A activity. In summary, our data suggest a potential beneficial role of biguanides such as metformin in the prophylaxis and/or therapy of AD.

Resveratrol is a polyphenolic phytoestrogen that has been shown to exhibit potent anti-oxidant, anti-inflammatory, and anti-catabolic properties. Increased osteoclastic and decreased osteoblastic activities result in bone resorption and loss of bone mass. These changes have been implicated in pathological processes in rheumatoid arthritis and osteoporosis. Receptor activator of NF-kappaB ligand (RANKL), a member of the TNF superfamily, is a major mediator of bone loss. In this study, we investigated the effects of resveratrol on RANKL during bone morphogenesis in high density bone cultures in vitro. Untreated bone-derived cell cultures produced well organized bone-like structures with a bone-specific matrix. Treatment with RANKL induced formation of tartrate-resistant acid phosphatase-positive multinucleated cells that exhibited morphological features of osteoclasts. RANKL induced NF-kappaB activation, whereas pretreatment with resveratrol completely inhibited this activation and suppressed the activation of IkappaBalpha kinase and IkappaBalpha phosphorylation and degradation. RANKL up-regulated p300 (a histone acetyltransferase) expression, which, in turn, promoted acetylation of NF-kappaB. Resveratrol inhibited RANKL-induced acetylation and nuclear translocation of NF-kappaB in a time- and concentration-dependent manner. In addition, activation of Sirt-1 (a histone deacetylase) by resveratrol induced Sirt-1-p300 association in bone-derived and preosteoblastic cells, leading to deacetylation of RANKL-induced NF-kappaB, inhibition of NF-kappaB transcriptional activation, and osteoclastogenesis. Co-treatment with resveratrol activated the bone transcription factors Cbfa-1 and Sirt-1 and induced the formation of Sirt-1-Cbfa-1 complexes. Overall, these results demonstrate that resveratrol-activated Sirt-1 plays pivotal roles in regulating the balance between the osteoclastic versus osteoblastic activity result in bone formation in vitro thereby highlighting its therapeutic potential for treating osteoporosis and rheumatoid arthritis-related bone loss.